Serum Heme Oxygenase-1 Level Predicts Clinical Outcome After Acute Ischemic Stroke
Overview
Affiliations
Aims: The relationship between heme oxygenase-1 (HO-1) and human ischemic stroke outcome remains unclear, which was investigated in this study.
Methods: Acute ischemic stroke patients admitted within 24 h were enrolled. Serum HO-1 levels at baseline were measured via ELISA. Poor 3-month functional outcome was defined as modified Rankin Scale (mRS) score 3-6. Multivariable-adjusted binary logistic regression and restricted cubic spline models were employed to examine association between serum HO-1 and functional outcome. HO-1's additive prognostic utility was assessed by net reclassification index (NRI) and integrated discrimination improvement (IDI).
Results: Of 194 eligible patients, 79 (40.7%) developed poor functional outcomes at 3-month follow-up. The highest quartile of serum HO-1 was independently associated with a lower risk of poor functional outcome (adjusted OR 0.13, 95% CI 0.04-0.45; p = 0.001) compared with the lowest HO-1 category. The relationship between higher HO-1 levels and reduced risk of poor functional outcome was linear and dose responsive (p = 0.002 for linearity). Incorporating HO-1 into the analysis with conventional factors significantly improved reclassification for poor functional outcomes (NRI = 41.2%, p = 0.004; IDI = 5.0%, p = 0.004).
Conclusions: Elevated serum HO-1 levels at baseline were independently associated with improved 3-month functional outcomes post-ischemic stroke. Serum HO-1 measurement may enhance outcome prediction beyond conventional clinical factors.
Zhu Y, Wang H, Cui T, Chen M, Chen Y, Wu S Ann Med. 2025; 57(1):2472867.
PMID: 40048365 PMC: 11892070. DOI: 10.1080/07853890.2025.2472867.
Serum heme oxygenase-1 level predicts clinical outcome after acute ischemic stroke.
Wang H, Cui T, Chen Y, Chen M, Zhang S, Leng X CNS Neurosci Ther. 2024; 30(3):e14701.
PMID: 38544366 PMC: 10973699. DOI: 10.1111/cns.14701.